Your browser doesn't support javascript.
loading
Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation.
Yao, Yuan; Li, Fan; Zhang, Mao; Jin, Li; Xie, Peng; Liu, Dairu; Zhang, Junxia; Hu, Xinli; Lv, Fengxiang; Shang, Haibao; Zheng, Wen; Sun, Xueting; Duanmu, Jiaxin; Wu, Fujian; Lan, Feng; Xiao, Rui-Ping; Zhang, Yan.
Afiliação
  • Yao Y; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Li F; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Zhang M; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Jin L; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Xie P; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Liu D; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Zhang J; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Hu X; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Lv F; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Shang H; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Zheng W; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Sun X; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Duanmu J; Institute of Cardiovascular Sciences and Key Laboratory of Molecular Cardiovascular Sciences, School of Basic Medical Sciences, Ministry of Education, Peking University Health Science Center, Beijing, China (J.D., Y.Z.).
  • Wu F; State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (F.W., F. Lan).
  • Lan F; State Key Laboratory of Cardiovascular Disease, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing (F.W., F. Lan).
  • Xiao RP; State Key Laboratory of Membrane Biology, Institute of Molecular Medicine, College of Future Technology (Y.Y., F. Li, M.Z., L.J., P.X., D.L., J.Z., X.H., F. Lv, H.S., W.Z., X.S., R.-P.X., Y.Z.), Peking University, Beijing, China.
  • Zhang Y; Beijing City Key Laboratory of Cardiometabolic Molecular Medicine (R.-P.X.), Peking University, Beijing, China.
Circ Res ; 130(6): 887-903, 2022 03 18.
Article em En | MEDLINE | ID: mdl-35152717
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão Miocárdica / Insuficiência Cardíaca / Miocardite Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Circ Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Traumatismo por Reperfusão Miocárdica / Insuficiência Cardíaca / Miocardite Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Circ Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China